APTEVO THERAPEUTICS INC (APVO) Stock Income Statement
NASDAQ:APVO - Nasdaq - US03835L4059 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 3.11M | 12.29M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 24.09M | 25.00M | 28.88M | 31.75M | 33.69M | |||
| Research and Development | 14.26M | N/A | 17.11M | 17.88M | 18.99M | |||
| Selling, General, and Administrative Expenses | 9.84M | 10.00M | 11.77M | 13.87M | 14.70M | |||
| Operating Income | -24.09M | -25.00M | -28.88M | -28.64M | -21.40M | |||
| Other Income/Expense | 394.00K | 470.00K | 578.00K | -1.53M | -8.01M | |||
| Non Recurring Items | N/A | N/A | 0.00 | 37.18M | 0.00 | |||
| Income Before Taxes | -23.70M | -24.00M | -18.65M | 7.01M | -29.41M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -23.70M | -24.00M | -17.41M | 8.03M | -28.46M | |||
| EBITDA | -23.79M | -24.65M | -28.31M | -27.74M | -20.26M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -18.74K | -64.86K | -45.82K | 50.17K | -203.26K | |||
| Non GAAP EPS | -3.33K | -10.60K | -48.19K | 51.44K | -198.29K | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | 257.77% | -231.51% | |||
| Operating Profit Margin | N/A | N/A | N/A | -919.75% | -174.10% | |||
All data in USD